Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC

PHASE2CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

June 29, 2017

Primary Completion Date

August 17, 2018

Study Completion Date

October 29, 2020

Conditions
Small Cell Lung Cancer
Interventions
DRUG

Trilaciclib

Trilaciclib IV

DRUG

Placebo

Placebo IV

DRUG

Carboplatin

Carboplatin IV

DRUG

Etoposide

Etoposide IV

DRUG

Atezolizumab

Atezolizumab IV

Trial Locations (45)

1303

"Multiprofile Hospital for Active Treatment Serdika, Sofia", Sofia

"Multiprofile Hospital for Active Treatment Serdika", Sofia

8000

Complex Oncology Center - Burgas, Burgas

10549

Northern Westchester Hospital, Mount Kisco

11312

East Tallinn Central Hospital Ltd., Clinic of Internal Medicine, Center for Oncology, Tallinn

14033

CHU Caen De La Côte De Nacre, Caen

15006

Hospital Teresa Herrera, A Coruña

20014

H. Donostia, Hospital Donostia- Servicio de Oncología, San Sebastián

22031

Virginia Cancer Specialists, Arlington

22060

Fort Belvoir Community Hospital, Fort Belvoir

24060

Blue Ridge Cancer Care, Blacksburg

28034

Hospital Universitario Ramón y Cajal, Madrid

28040

Hospital Clínico, San Carlos

28041

Hospital 12 de Octubre, Madrid

28222

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda

29303

Gibbs Cancer Center, Spartanburg

30318

Piedmont Cancer Institute, Atlanta

30341

Northside Hospital - Georgia Cancer Specialists, Atlanta

41014

Hospital Universitario Ntra. Sra. de Valme, Seville

46015

Hospital Arnau de Vilanova, Valencia

47905

Horizon Oncology Center, Lafayette

49102

Dnipropetrovsk City Multispecialty Clinical Hospital #4, Dnipro

58013

Chernivtsi Regional Clinical Oncology Center, Chernivtsi

58701

Trinity Health - Trinity CancerCare Center, Minot

59020

Centre Oscar Lambret, Lille

60435

Joliet Oncology-Hematology Associates, Joliet

63044

St. Louis Cancer Care, LLP, North County, Bridgeton

70121

Ochsner Clinic Foundation, New Orleans

73117

Oklahoma University - Peggy and Charles Stephenson Cancer Center, Oklahoma City

77090

Millennium Oncology, Houston

78550

Valley Cancer Associates, Harlingen

79031

Lviv State Regional Treatment and Diagnostics Oncology Center, Lviv

90211

Beverly Hills Cancer Center, Beverly Hills

90404

UCLA Medical Center - Santa Monica Hematology And Oncology, Santa Monica

90603

Singing River Health System, Whittier

92350

Loma Linda University, Loma Linda

92835

St. Jude Heritage Healthcare, Fullerton

95403

Redwood Regional Medical Group (RRMG) - Fountain Grove, Santa Rosa

63110-1094

The Alvin J. Siteman Cancer Center - Center for Advanced Med, St Louis

07962

Summit Medical Group, P.A., Morristown

LV-5417

Daugavpils Regional Hospital, Department of Oncology, Daugavpils

LV-1002

Pauls Stradiņš Clinical University Hospital, Oncology Clinic, Riga

07120

Hospital Universitario Son Espases, Palma

08028

H.U. Quirón Dexeus, Hospital Universitario, Barcelona

08036

Hospital Clinic de Barcelona- Servicio de Oncología Médica, Barcelona

Sponsors
All Listed Sponsors
collaborator

Roche-Genentech

INDUSTRY

lead

G1 Therapeutics, Inc.

INDUSTRY